Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8819 |
High Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.8803 |
High Similarity |
NPD3750 |
Approved |
0.8686 |
High Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.8601 |
High Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.8593 |
High Similarity |
NPD2797 |
Approved |
0.8591 |
High Similarity |
NPD7411 |
Suspended |
0.8571 |
High Similarity |
NPD422 |
Phase 1 |
0.8562 |
High Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.8487 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.8451 |
Intermediate Similarity |
NPD3748 |
Approved |
0.8431 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.8417 |
Intermediate Similarity |
NPD3268 |
Approved |
0.8411 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.8403 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.8392 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.8369 |
Intermediate Similarity |
NPD5123 |
Clinical (unspecified phase) |
0.8369 |
Intermediate Similarity |
NPD5124 |
Phase 1 |
0.8355 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8355 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8344 |
Intermediate Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.8333 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.8322 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.8298 |
Intermediate Similarity |
NPD1240 |
Approved |
0.8288 |
Intermediate Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.8286 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.8278 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8264 |
Intermediate Similarity |
NPD2796 |
Approved |
0.8264 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.8248 |
Intermediate Similarity |
NPD3225 |
Approved |
0.8247 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8243 |
Intermediate Similarity |
NPD6799 |
Approved |
0.8235 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.82 |
Intermediate Similarity |
NPD920 |
Approved |
0.8194 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.8194 |
Intermediate Similarity |
NPD4308 |
Phase 3 |
0.8188 |
Intermediate Similarity |
NPD1203 |
Approved |
0.8182 |
Intermediate Similarity |
NPD1607 |
Approved |
0.8156 |
Intermediate Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.8156 |
Intermediate Similarity |
NPD1296 |
Phase 2 |
0.8134 |
Intermediate Similarity |
NPD1548 |
Phase 1 |
0.8117 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8113 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.8095 |
Intermediate Similarity |
NPD1243 |
Approved |
0.8079 |
Intermediate Similarity |
NPD5403 |
Approved |
0.8077 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8077 |
Intermediate Similarity |
NPD3749 |
Approved |
0.8075 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8067 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.8065 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.8058 |
Intermediate Similarity |
NPD3266 |
Approved |
0.8058 |
Intermediate Similarity |
NPD3267 |
Approved |
0.8041 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.8039 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.8027 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.8014 |
Intermediate Similarity |
NPD4908 |
Phase 1 |
0.8014 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.8 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7987 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7974 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7971 |
Intermediate Similarity |
NPD9717 |
Approved |
0.7963 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7949 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7949 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7947 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7947 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7945 |
Intermediate Similarity |
NPD7033 |
Discontinued |
0.7935 |
Intermediate Similarity |
NPD1934 |
Approved |
0.7933 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7919 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7917 |
Intermediate Similarity |
NPD4307 |
Phase 2 |
0.7902 |
Intermediate Similarity |
NPD6798 |
Discontinued |
0.7899 |
Intermediate Similarity |
NPD1610 |
Phase 2 |
0.7895 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7885 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7866 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7853 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.7852 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7852 |
Intermediate Similarity |
NPD1652 |
Phase 2 |
0.7842 |
Intermediate Similarity |
NPD1481 |
Phase 2 |
0.784 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7838 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7834 |
Intermediate Similarity |
NPD4288 |
Approved |
0.7818 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.7791 |
Intermediate Similarity |
NPD3818 |
Discontinued |
0.7785 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD3764 |
Approved |
0.777 |
Intermediate Similarity |
NPD1535 |
Discovery |
0.7764 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7762 |
Intermediate Similarity |
NPD1008 |
Clinical (unspecified phase) |
0.7724 |
Intermediate Similarity |
NPD6233 |
Phase 2 |
0.7718 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7714 |
Intermediate Similarity |
NPD1608 |
Approved |
0.7708 |
Intermediate Similarity |
NPD4625 |
Phase 3 |
0.7702 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7687 |
Intermediate Similarity |
NPD5535 |
Approved |
0.7682 |
Intermediate Similarity |
NPD7003 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6100 |
Approved |
0.7651 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD4477 |
Approved |
0.7651 |
Intermediate Similarity |
NPD4476 |
Approved |
0.7651 |
Intermediate Similarity |
NPD6099 |
Approved |
0.764 |
Intermediate Similarity |
NPD5494 |
Approved |
0.7639 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7628 |
Intermediate Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.7625 |
Intermediate Similarity |
NPD6971 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7619 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7619 |
Intermediate Similarity |
NPD6355 |
Discontinued |
0.7619 |
Intermediate Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.7609 |
Intermediate Similarity |
NPD9545 |
Approved |
0.7609 |
Intermediate Similarity |
NPD1894 |
Discontinued |
0.76 |
Intermediate Similarity |
NPD6005 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD6003 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6002 |
Phase 3 |
0.76 |
Intermediate Similarity |
NPD6006 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD6004 |
Phase 3 |
0.7597 |
Intermediate Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.7595 |
Intermediate Similarity |
NPD37 |
Approved |
0.7578 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7578 |
Intermediate Similarity |
NPD919 |
Approved |
0.7569 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7568 |
Intermediate Similarity |
NPD6651 |
Approved |
0.7564 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7562 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7561 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.7561 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.756 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.7551 |
Intermediate Similarity |
NPD4060 |
Phase 1 |
0.7551 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7551 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7547 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7532 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.753 |
Intermediate Similarity |
NPD7054 |
Approved |
0.75 |
Intermediate Similarity |
NPD2798 |
Approved |
0.75 |
Intermediate Similarity |
NPD1933 |
Approved |
0.75 |
Intermediate Similarity |
NPD1241 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD1019 |
Discontinued |
0.75 |
Intermediate Similarity |
NPD17 |
Approved |
0.7485 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.7485 |
Intermediate Similarity |
NPD7472 |
Approved |
0.7483 |
Intermediate Similarity |
NPD2344 |
Approved |
0.7483 |
Intermediate Similarity |
NPD1283 |
Approved |
0.7468 |
Intermediate Similarity |
NPD7440 |
Discontinued |
0.7468 |
Intermediate Similarity |
NPD6502 |
Phase 2 |
0.7464 |
Intermediate Similarity |
NPD9493 |
Approved |
0.7456 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.7447 |
Intermediate Similarity |
NPD3847 |
Discontinued |
0.744 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7436 |
Intermediate Similarity |
NPD5049 |
Phase 3 |
0.7436 |
Intermediate Similarity |
NPD6273 |
Approved |
0.7415 |
Intermediate Similarity |
NPD411 |
Approved |
0.7413 |
Intermediate Similarity |
NPD4749 |
Approved |
0.7405 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.74 |
Intermediate Similarity |
NPD7097 |
Phase 1 |
0.7396 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7394 |
Intermediate Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.7383 |
Intermediate Similarity |
NPD4618 |
Approved |
0.7383 |
Intermediate Similarity |
NPD4622 |
Approved |
0.7383 |
Intermediate Similarity |
NPD4340 |
Discontinued |
0.7378 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7376 |
Intermediate Similarity |
NPD4626 |
Approved |
0.7365 |
Intermediate Similarity |
NPD4062 |
Phase 3 |
0.7355 |
Intermediate Similarity |
NPD6666 |
Approved |
0.7355 |
Intermediate Similarity |
NPD6667 |
Approved |
0.7353 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7351 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7347 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7345 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7333 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7333 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7329 |
Intermediate Similarity |
NPD2861 |
Phase 2 |
0.7324 |
Intermediate Similarity |
NPD3496 |
Discontinued |
0.732 |
Intermediate Similarity |
NPD2424 |
Discontinued |
0.7315 |
Intermediate Similarity |
NPD2979 |
Phase 3 |
0.731 |
Intermediate Similarity |
NPD1164 |
Approved |
0.7308 |
Intermediate Similarity |
NPD7213 |
Phase 3 |
0.7308 |
Intermediate Similarity |
NPD7212 |
Phase 2 |
0.7303 |
Intermediate Similarity |
NPD5405 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5404 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5406 |
Approved |
0.7303 |
Intermediate Similarity |
NPD5408 |
Approved |
0.7297 |
Intermediate Similarity |
NPD6410 |
Clinical (unspecified phase) |
0.7296 |
Intermediate Similarity |
NPD8158 |
Clinical (unspecified phase) |
0.7293 |
Intermediate Similarity |
NPD9697 |
Approved |
0.729 |
Intermediate Similarity |
NPD2309 |
Approved |
0.729 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7289 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7285 |
Intermediate Similarity |
NPD5689 |
Approved |
0.7285 |
Intermediate Similarity |
NPD5688 |
Approved |
0.7279 |
Intermediate Similarity |
NPD2614 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1281 |
Approved |
0.7273 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7262
|
Intermediate Similarity |
NPD7228 |
Approved |